-
1
-
-
0015046084
-
Immunosuppressant agents in the treatment of glomerulonephritis. 1. Corticosteroid drugs
-
Cameron JS. Immunosuppressant agents in the treatment of glomerulonephritis. 1. Corticosteroid drugs. J R Coll Physicians Lond 1971: 5: 282-296
-
(1971)
J. R. Coll. Physicians Lond.
, vol.5
, pp. 282-296
-
-
Cameron, J.S.1
-
2
-
-
0015046271
-
Long-term steroid-immunosuppressive treatment of the childhood nephrotic syndrome
-
Pachioli R, Genova R. Long-term steroid-immunosuppressive treatment of the childhood nephrotic syndrome. Pediatrics 1971; 47: 731-736
-
(1971)
Pediatrics
, vol.47
, pp. 731-736
-
-
Pachioli, R.1
Genova, R.2
-
4
-
-
2442458099
-
Studies on the influence of adrenocorticotrophin in acute nephritis, in simple nephrosis and in nephrosis with azotemia
-
Mote JR, ed. Blakiston, PA
-
Farnsworth FB. Studies on the influence of adrenocorticotrophin in acute nephritis, in simple nephrosis and in nephrosis with azotemia. In: Mote JR, ed. Proceedings of the First Clinical ACTH Congress. Blakiston, PA: 1950; 297-317
-
(1950)
Proceedings of the First Clinical ACTH Congress
, pp. 297-317
-
-
Farnsworth, F.B.1
-
5
-
-
0032843525
-
Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy
-
Berg AL, Nilsson-Ehle P, Arnadottir M. Beneficial effects of ACTH on the serum lipoprotein profile and glomerular function in patients with membranous nephropathy. Kidney Int 1999: 56: 1534-1543
-
(1999)
Kidney Int.
, vol.56
, pp. 1534-1543
-
-
Berg, A.L.1
Nilsson-Ehle, P.2
Arnadottir, M.3
-
6
-
-
0028785260
-
A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy
-
Ponticelli C, Zuchelli P, Passerini P et al. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int 1995; 48: 1600-1604
-
(1995)
Kidney Int.
, vol.48
, pp. 1600-1604
-
-
Ponticelli, C.1
Zuchelli, P.2
Passerini, P.3
-
7
-
-
0016345829
-
Controlled trial of cyclophosphamide in idiopathic membranous nephropathy
-
Donadio JV, Holley KE, Andersson CF, Taylor WF. Controlled trial of cyclophosphamide in idiopathic membranous nephropathy. Kidney Int 1974; 16: 431-439
-
(1974)
Kidney Int.
, vol.16
, pp. 431-439
-
-
Donadio, J.V.1
Holley, K.E.2
Andersson, C.F.3
Taylor, W.F.4
-
8
-
-
0028941295
-
A controlled trial of cyclosporin in patients with progressive membranous nephropathy
-
Cattran DC, Greenwood C, Ritchie S et al. A controlled trial of cyclosporin in patients with progressive membranous nephropathy. Kidney Int 1995; 47: 1130-1135
-
(1995)
Kidney Int.
, vol.47
, pp. 1130-1135
-
-
Cattran, D.C.1
Greenwood, C.2
Ritchie, S.3
-
9
-
-
0028058083
-
Direct effects of ACTH on plasma lipoprotein metabolism in man: Studies in vivo and in vitro
-
Berg AL, Nilsson-Ehle P. Direct effects of ACTH on plasma lipoprotein metabolism in man: Studies in vivo and in vitro. Metabolism 1994: 43: 90
-
(1994)
Metabolism
, vol.43
, pp. 90
-
-
Berg, A.L.1
Nilsson-Ehle, P.2
-
10
-
-
0029839797
-
ACTH lowers serum lipids in steroid treated hyperlipidemic patients with kidney disease
-
Berg AL, Nilsson-Ehle P. ACTH lowers serum lipids in steroid treated hyperlipidemic patients with kidney disease. Kidney Int 50; 1996: 538-542
-
(1996)
Kidney Int.
, vol.50
, pp. 538-542
-
-
Berg, A.L.1
Nilsson-Ehle, P.2
-
11
-
-
0031449481
-
Adrenocorticotrophic hormone lowers serum Lp(a) and LDL cholesterol concentrations but does not influence triglyceride metabolism in hemodialysis patients
-
Arnadottir M, Berg AL, Dallongeville J, Fruchart JC, Nilsson-Ehle P. Adrenocorticotrophic hormone lowers serum Lp(a) and LDL cholesterol concentrations but does not influence triglyceride metabolism in hemodialysis patients. Kidney Int 1997; 52: 1651-1655
-
(1997)
Kidney Int.
, vol.52
, pp. 1651-1655
-
-
Arnadottir, M.1
Berg, A.L.2
Dallongeville, J.3
Fruchart, J.C.4
Nilsson-Ehle, P.5
-
12
-
-
0027989569
-
Lipids and the kidney
-
Keane WF. Lipids and the kidney. Kidney Int 1994; 46: 910-920
-
(1994)
Kidney Int.
, vol.46
, pp. 910-920
-
-
Keane, W.F.1
-
13
-
-
0030627606
-
Effect of lipid-lowering therapy on the progression of renal disease in non-diabetic nephrotic patients
-
Keane WF, Hörl WH, Kasiske B, eds. Karger, Basel
-
Neverov NI, Kaysen GA, Taryeva IE. Effect of lipid-lowering therapy on the progression of renal disease in non-diabetic nephrotic patients. In: Keane WF, Hörl WH, Kasiske B, eds. Contributions to Nephrology (vol 120). Karger, Basel: 1997; 68-78
-
(1997)
Contributions to Nephrology
, vol.120
, pp. 68-78
-
-
Neverov, N.I.1
Kaysen, G.A.2
Taryeva, I.E.3
-
14
-
-
0027482701
-
Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria
-
Thomas ME, Harris KPG, Ramaswamy C et al. Simvastatin therapy for hypercholesterolemic patients with nephrotic syndrome or significant proteinuria. Kidney Int 1993; 44: 1124-1129
-
(1993)
Kidney Int.
, vol.44
, pp. 1124-1129
-
-
Thomas, M.E.1
Harris, K.P.G.2
Ramaswamy, C.3
-
15
-
-
0034082529
-
Chronic proteinuric nephropathies: Outcomes and response to treatment in a prospective cohort of 352 patients with a different pattern of renal injury
-
Ruggenenti P, Perna A, Gherardi G, Benini R, Remuzzi G. Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with a different pattern of renal injury. Am J Kidney Dis 2000; 35: 1155-1165
-
(2000)
Am. J. Kidney Dis.
, vol.35
, pp. 1155-1165
-
-
Ruggenenti, P.1
Perna, A.2
Gherardi, G.3
Benini, R.4
Remuzzi, G.5
|